Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide plus chlorthalidone vs high-dose furosemide in advanced chronic kidney disease
TCTR20240317001Phase 2Completed
- Sponsor
- Phramongkutklao Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of furosemide, chlorthalidone in chronic kidney disease (CKD), sponsored by Phramongkutklao Hospital. Started Mar 2023; status: completed.
02
Drugs
furosemidechlorthalidone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on TCTR20240317001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240317001.